PINNACLE ASSOCIATES LTD - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 162 filers reported holding ANTARES PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
PINNACLE ASSOCIATES LTD ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$270,000
+14.9%
65,8230.0%0.01%
+25.0%
Q4 2021$235,000
-2.1%
65,8230.0%0.00%0.0%
Q3 2021$240,000
-16.4%
65,8230.0%0.00%
-20.0%
Q2 2021$287,000
+4.7%
65,823
-1.3%
0.01%0.0%
Q1 2021$274,000
+3.0%
66,6730.0%0.01%0.0%
Q4 2020$266,000
+47.8%
66,6730.0%0.01%
+25.0%
Q3 2020$180,000
-0.6%
66,673
+1.5%
0.00%0.0%
Q2 2020$181,000
-9.0%
65,673
-22.2%
0.00%
-33.3%
Q1 2020$199,000
-11.6%
84,405
+76.6%
0.01%
+20.0%
Q4 2019$225,000
+11.4%
47,790
-20.7%
0.01%0.0%
Q3 2019$202,000
+2.0%
60,2400.0%0.01%0.0%
Q2 2019$198,00060,2400.01%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,180,0004.34%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,535,727$11,056,0003.87%
Sargent Investment Group, LLC 3,596,250$15,680,0003.72%
Rubric Capital Management LP 9,500,000$41,420,0002.61%
PERKINS CAPITAL MANAGEMENT INC 541,783$2,362,0001.34%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$8,284,0001.14%
Venator Capital Management Ltd. 709,700$3,094,0001.05%
LEVEL FOUR FINANCIAL, LLC 120,000$523,0000.22%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$875,0000.19%
Brown Advisory Securities, LLC 275,000$1,199,0000.19%
View complete list of ANTARES PHARMA INC shareholders